Abstract Omental gangrene is an infrequent cause of acute abdomen with unclear etiology. Hypercoagualable states like protein C or protein S deficiency have never been implicated in the etiology of omental gangrene. We present this case report of a patient having protein C and protein S deficiency presenting with omental gangrene and extensive porto mesenteric thrombosis.
Introduction
Inherited thrombophilias like deficiency of protein C, protein S, antithrombin III, factor V Leiden and high levels of clotting factors VII, IX, XI are associated with increased risk of venous thromboembolism [1] . The deep veins of lower extremity, mesenteric veins and cerebral sinuses are most frequently involved. Arterial thrombosis although described is rare. Protein C and protein S deficiencies causing omental gangrene has not been reported in the literature.
Case Report
A 41-year-old female patient presented with acute onset of lower abdominal pain and fever for 7 days. There were no bladder, bowel or menstrual complaints. On retrospective inquiry, the patient gave history of taking Norethisterone tablets for prolongation of her menstrual cycles 8 days prior to onset of symptoms. The patient had undergone two cesarean sections in the past. On examination, the patient had tenderness in the right iliac fossa with no guarding or rigidity. No lump was palpable. Other system examination was unremarkable. A clinical diagnosis of acute appendicitis was made. The total WBC count was 23,100/mm 3 . Ultrasound examination of abdomen revealed probe tenderness in the right iliac fossa. CT scan showed wall thickening of the cecum and ascending colon and ascites. Colonoscopy findings included right-sided non-specific colitis. Laparoscopy was done with acute appendicitis as the probable diagnosis. Pneumoperitoneum was created by closed technique using the veress needle and a 10-mm optical trocar was introduced at the umbilicus. There was evidence of primary omental gangrene involving the right half of omentum with hemorrhagic fluid collection (Fig. 1) . The small bowel and colon were found to be normal. 5-mm working ports were introduced in the left hypochondrium and left iliac fossa. The gangrenous segment of omentum was excised using ultraciscion. Hemorrhagic fluid was aspirated, peritoneal lavage given and abdominal drain kept in the pelvis. Postoperatively the patient had excessive drainage of clear transudative ascitic fluid from the drain (600-800 ml/day). Hepatic, renal and cardiac causes of ascites were ruled out by relevant investigations. On the 4th post-operative day, the patient had acute episode of severe generalized abdominal pain with no signs of peritonitis or intestinal obstruction. CT scan abdomen with angiography revealed extensive thrombosis of superior mesenteric vein extending to the portal vein and also involving the left renal vein (Fig. 2) . The patient was managed with heparin therapy and diuretics along with supportive measures. The patient responded well to the conservative management with reduction of abdominal pain and drain output. The patient was discharged on the 11th post-operative day on oral anticoagulants. The investigations for hypercoagulable states revealed protein C and protein S deficiencies.
Discussion
Proteins C and S are vitamin K-dependent proteins. Protein C inactivates factors Va, factor VIIIa and the inhibitor to tissue plasminogen activator, whereas protein S is a cofactor for protein C [2] . Proteins C and S deficiencies are autosomal dominant hypercoagulable states. The risk of venous thrombosis in this population is roughly sevenfold over that of the general population [3] . Approximately, 40 % of these patients with venous thromboembolism have one of the usual thrombotic risk factors like pregnancy, hormone therapy, surgery or immobilization [4] . The remaining 60 % present with unprovoked venous thrombosis. There are several reports of arterial occlusive stroke and myocardial infarction in patients with low protein C and/or S levels [5] [6] [7] . Similarly peripheral arterial ischemia has also been reported in these patients [2] . However, there are no previous reports of omental gangrene in a patient of protein C or protein S deficiency. The authors have published a series of nine patients of omental torsion and infarction [8] . None of the patients of omental infarction in that series were diagnosed to have hypercoagulable states. The omental gangrene in the index case was perhaps due to thrombosis of the right gastro epiploic vessels as a part of the extensive thrombosis of the portal and systemic circulation. Whether the thrombosis was precipitated by intake of Norethisterone is debatable. Many reports suggest that Norethisterone causes reduced protein C and S levels. In a randomized controlled trial, significant decrease in the activity of antithrombin III and protein C and levels of plasminogen activator inhibitor 1 antigen were found as compared to placebo at 6 months of continuous combined hormone replacement therapy (Estradiol 2 mg/ day and Norethisterone 1 mg/day) [9] . Another study showed significant decrease in protein S secondary to use on cyclical sequential combined HRT regimen containing estrogen and Norethisterone [10] . The GTH study group mentioned recurrent thrombosis rate of 63 % in patients with antithrombin III, protein C and protein S deficiencies with 60 % of recurrent events occurring spontaneously [11] . Hence, these patients require life-long oral anticoagulant therapy with warfarin, and the INR is maintained between 2 and 3. These patients are counseled regarding further risks of ischemia and the need for life-long oral anticoagulant therapy. Female patients are advised to be careful and weigh the benefits of oral contraceptive pills and hormone replacement therapy against the increased risk of thrombosis
Conclusion
Patients of omental gangrene may have associated protein C and/or S deficiency. Hypercoagulable states must be ruled out while managing these patients for better outcomes. Patients with extensive portomesenteric thrombosis can be effectively managed with anticoagulant therapy.
